International audienceBackground Comorbidities including cardiovascular diseases are very common in chronic obstructive pulmonary disease (COPD) secondary to tobacco smoking and contribute to the overall severity of the disease. In non-smoking COPD, which accounts for about 25% of COPD cases worldwide, current knowledge on the frequency and determinants of comorbidities remains scarce. The aims of the current study were to assess the frequency of major comorbidities and to evaluate their determinants in a group of non-selected patients with mild-to-moderate COPD who were exposed to organic dust (dairy farmers), to tobacco smoking, or to both, and in controls without COPD who were exposed to organic dust (dairy farmers), or to tobacco smokin...
Tobacco smoking is a major risk factor for chronic obstructive pulmonary disease (COPD), a debilitat...
BACKGROUND: While inhaled bronchodilators reduce symptoms and acute exacerbations of chronic obstruc...
International audienceBACKGROUND: The contribution of occupational exposures to COPD and their inter...
International audienceBackground Comorbidities including cardiovascular diseases are very common in ...
Cardiovascular diseases are the most common comorbidities in COPD, due to common risk factors such a...
Background: Smoking and bronchodilator treatment are both extensively studied as key elements in pat...
Cardiovascular diseases are the most common comorbidities in COPD, due to common risk factors such a...
BACKGROUND: Comorbidities associated with systemic inflammation including cardiovascular disease (CV...
Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction and often co-ex...
Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction and often co-ex...
There is compelling epidemiological evidence that airway exposure to cigarette smoke, air pollution ...
BACKGROUND Chronic Obstructive Pulmonary Disease (COPD) is the fourth largest cause of death worldwi...
BACKGROUND: Chronic mucus hypersecretion (CMH) is highly prevalent in smokers and associated with an...
Background Chronic mucus hypersecretion (CMH) is highly prevalent in smokers and associated with an ...
Background Chronic mucus hypersecretion (CMH) is highly prevalent in smokers and associated with an ...
Tobacco smoking is a major risk factor for chronic obstructive pulmonary disease (COPD), a debilitat...
BACKGROUND: While inhaled bronchodilators reduce symptoms and acute exacerbations of chronic obstruc...
International audienceBACKGROUND: The contribution of occupational exposures to COPD and their inter...
International audienceBackground Comorbidities including cardiovascular diseases are very common in ...
Cardiovascular diseases are the most common comorbidities in COPD, due to common risk factors such a...
Background: Smoking and bronchodilator treatment are both extensively studied as key elements in pat...
Cardiovascular diseases are the most common comorbidities in COPD, due to common risk factors such a...
BACKGROUND: Comorbidities associated with systemic inflammation including cardiovascular disease (CV...
Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction and often co-ex...
Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction and often co-ex...
There is compelling epidemiological evidence that airway exposure to cigarette smoke, air pollution ...
BACKGROUND Chronic Obstructive Pulmonary Disease (COPD) is the fourth largest cause of death worldwi...
BACKGROUND: Chronic mucus hypersecretion (CMH) is highly prevalent in smokers and associated with an...
Background Chronic mucus hypersecretion (CMH) is highly prevalent in smokers and associated with an ...
Background Chronic mucus hypersecretion (CMH) is highly prevalent in smokers and associated with an ...
Tobacco smoking is a major risk factor for chronic obstructive pulmonary disease (COPD), a debilitat...
BACKGROUND: While inhaled bronchodilators reduce symptoms and acute exacerbations of chronic obstruc...
International audienceBACKGROUND: The contribution of occupational exposures to COPD and their inter...